- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 269/02 - Heterocyclic compounds containing rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms according to more than one of groups having the hetero atoms in positions 1 and 3
Patent holdings for IPC class C07D 269/02
Total number of patents in this class: 29
10-year publication summary
|
1
|
2
|
1
|
3
|
2
|
4
|
1
|
0
|
0
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Ligand Pharmaceuticals Incorporated | 167 |
6 |
| Green Cross Corporation | 219 |
3 |
| Guangzhou ChinaRay Optoelectronic Materials Ltd. | 150 |
3 |
| Biomatrica, Inc. | 45 |
2 |
| Hinova Pharmaceuticals Inc. | 102 |
2 |
| Exonate Limited | 15 |
2 |
| Lonza Guangzhou Research and Development Center Ltd. | 7 |
1 |
| Lonza Ltd. | 586 |
1 |
| Newsouth Innovations Pty Limited | 619 |
1 |
| Shanghai Pharmaceuticals Holding Co., Ltd. | 108 |
1 |
| Tianjin Chasesun Pharmaceutical Co., Ltd | 13 |
1 |
| The University of Nottingham | 328 |
1 |
| Vivace Therapeutics, Inc. | 32 |
1 |
| sanofi-aventis | 297 |
1 |
| Institute of Zoology, Guangdong Academy of Sciences | 21 |
1 |
| Yantai Haisen Big Data Company Limited | 2 |
1 |
| Yantai Xianhua Optoelectronics Institute Corporation Limited | 2 |
1 |
| Other owners | 0 |